Shepherd Kaplan Krochuk’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-7,790	Closed	-$587K	–	502
2015 Q2	$587K	Sell	7,790 -2,071	-21%	-$111K	0.11%	151
2015 Q1	$495K	Hold	9,861	–	–	0.09%	175
2014 Q4	$342K	Hold	9,861	–	–	0.06%	257
2014 Q3	$323K	Buy	9,861 +890	+10%	+$31.3K	0.04%	294
2014 Q2	$344K	Hold	8,971	–	–	0.04%	284
2014 Q1	$357K	Sell	8,971 -1,126	-11%	-$50.4K	0.04%	268
2013 Q4	$377K	Hold	10,097	–	–	0.05%	257
2013 Q3	$460K	Hold	10,097	–	–	0.07%	211
2013 Q2	$273K	Buy	+10,097	New	+$231K	0.05%	322

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Shepherd Kaplan Krochuk's KYTH Position: Q3 2015 in Review

Shepherd Kaplan Krochuk sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015, closing a stake of 7,790 shares — an estimated $587K sold.

Shepherd Kaplan Krochuk first reported a position in KYTH in Q2 2013 and held it in 9 quarters. The position peaked at $587K in Q2 2015. 143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

Shepherd Kaplan Krochuk reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q3 2015 after selling out during the quarter.
Shepherd Kaplan Krochuk sold 7,790 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q3 2015, an estimated $587K.
Shepherd Kaplan Krochuk first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2013 and held it in 9 quarters.
Shepherd Kaplan Krochuk's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $587K in Q2 2015.
143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Shepherd Kaplan Krochuk's 13F filing for Q3 2015, filed 16 Nov 2015.